RXRG as a Novel Biomarker and its Correlation With Immune Infiltration in Thyroid Carcinoma
Abstract Background/Aim: Thyroid carcinoma (THCA) is the most prevalent type of endocrine cancer. Retinoid X Receptor Gamma (RXRG) encodes a member of the retinoid X receptor (RXR) family of nuclear receptors that are involved in mediating the antiproliferative effects of retinoic acid (RA). However, the role of RXRG in THCA remains unclear. Materials and Methods: Multiple public databases were utilized to investigate RXRG expression in THCA and its role in THCA prognosis, analyze the RXRG co-expressed genes and protein-protein interaction
This article is available to registered members
Create a free account to access our full library of peer-reviewed research on medical cannabis.
Join — it's freeAlready a member? Log in
